27Serious

Adam Robitel

Ask VT AI

View News Summary

Eli Lilly posts blowout Q3 results, raises 2025 outlook, and sees strong demand for its GLP-1 medicines.
Supreme Court delays ruling on Trump's National Guard deployment to Illinois, seeking clarification on the scope of presidential authority to use troops for domestic law enforcement without state consent.
Novo Nordisk challenges Pfizer's acquisition of Metsera with a $6.5 billion bid, sparking a high-stakes contest for obesity and GLP-1 assets.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Ask VT AI

View News Summary

Eli Lilly posts blowout Q3 results, raises 2025 outlook, and sees strong demand for its GLP-1 medicines.
Supreme Court delays ruling on Trump's National Guard deployment to Illinois, seeking clarification on the scope of presidential authority to use troops for domestic law enforcement without state consent.
Novo Nordisk challenges Pfizer's acquisition of Metsera with a $6.5 billion bid, sparking a high-stakes contest for obesity and GLP-1 assets.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Most Reported By
News from Adam Robitel